Genetics and Genomics: From Genes to Genomes

Introduction to Genetics and Genomics

Genetics is the study of heredity—how traits are passed from parents to offspring—and of the molecular mechanisms controlling gene expression and function. Genomics extends this to the complete set of genetic information in an organism, analysing structure, function, evolution, and mapping of genomes. Together they explain biological variation from individual differences in disease susceptibility to the evolutionary divergence of species, and they underpin modern medicine through genetic diagnosis, pharmacogenomics, and gene therapy.

The discovery that DNA is the chemical basis of heredity, elucidation of the double helix structure, and deciphering the genetic code established the molecular foundation. The Human Genome Project (completed 2003) determined the complete 3 billion base pair human genome sequence. Next-generation sequencing technologies have since reduced genome sequencing costs from $3 billion to under $500, enabling population-scale genomics that is revealing the genetic architecture of complex diseases with unprecedented resolution.

Molecular Genetics

Gene Regulation and Epigenetics

Gene expression is regulated at multiple levels: transcription factor binding at promoters and enhancers determines when and where genes are transcribed; RNA splicing determines which exons are included in mRNA; RNA stability and translation efficiency govern protein production; post-translational modifications regulate protein activity. Epigenetic regulation—chromatin modifications including DNA methylation (CpG), histone acetylation, methylation, and phosphorylation—establishes heritable gene expression patterns without DNA sequence changes. Polycomb and Trithorax complexes maintain silenced and active chromatin states respectively; their disruption occurs in many cancers.

DNA Replication and Repair

DNA replication uses the existing strand as a template; DNA polymerase synthesises new strands 5' to 3' with a proofreading exonuclease activity reducing error rate to approximately 1 in 10^9 bases per replication. Replication begins at multiple origins on eukaryotic chromosomes, firing sequentially during S phase. DNA damage from UV radiation, reactive oxygen species, replication errors, and exogenous genotoxins is repaired by multiple pathways: nucleotide excision repair (bulky adducts), base excision repair (oxidised/alkylated bases), mismatch repair (replication errors), homologous recombination, and non-homologous end joining (double strand breaks). Mutations in repair genes (MSH2 in Lynch syndrome, BRCA1/2) increase cancer risk dramatically.

Complex Trait Genetics

Genome-Wide Association Studies

GWAS test millions of single nucleotide polymorphisms (SNPs) across the genome for statistical association with traits or diseases in large cohorts. By 2025, GWAS had identified thousands of variants associated with complex diseases (type 2 diabetes, Alzheimer's, schizophrenia, height, BMI). Most GWAS hits are in non-coding regulatory regions, revealing the importance of gene regulation variants in complex trait architecture. Polygenic risk scores (PRS) aggregate GWAS data to predict individual disease risk and are entering clinical use for cardiovascular disease, breast cancer, and other conditions.

Population Genomics

Population genomics analyses genome-wide variation in many individuals to infer evolutionary history, population structure, and natural selection. Fst statistics identify genetic differentiation between populations; extended haplotype homozygosity signals recent positive selection. The 1000 Genomes Project catalogued variation across 26 human populations; large biobanks (UK Biobank, All of Us, FinnGen) enable massive genotype-phenotype studies. Population genomics has documented human migration out of Africa, population bottlenecks, and admixture events—ancient DNA from archaeological specimens directly observing prehistoric population movements.

Genomic Technologies and Applications

Long-read sequencing technologies (PacBio, Oxford Nanopore) can now sequence through repetitive regions and structural variants inaccessible to short reads. Telomere-to-telomere human genome sequencing (T2T) completed what the Human Genome Project left unfinished—all centromeres and other highly repetitive regions. Single-cell genomics profiles gene expression, chromatin accessibility, and genome sequences of individual cells, revealing cell type diversity and developmental trajectories. Spatial transcriptomics maps gene expression within tissue context, connecting molecular profiles to histology. Proteomics, metabolomics, and other 'omics layers add dimensionality to genomic understanding.

Examples and Applications

Example 1: BRCA1/2 Breast and Ovarian Cancer

BRCA1 and BRCA2 are tumour suppressor genes involved in homologous recombination DNA repair. Pathogenic variants confer 50-70% lifetime breast cancer risk and 20-40% ovarian cancer risk. Genetic testing identifies variant carriers who can take preventive measures: enhanced surveillance, risk-reducing mastectomy or salpingo-oophorectomy. PARP inhibitors (olaparib) exploit BRCA-deficient cancer cells' inability to use homologous recombination by blocking base excision repair backup—synthetic lethality. Understanding BRCA biology thus underpins both prevention strategies and targeted therapy.

Example 2: Newborn Screening Genomics

Over 30 metabolic disorders are screened in newborn blood spots by tandem MS. Whole-genome sequencing of critically ill newborns can diagnose rare genetic diseases within 24-48 hours—dramatically faster than conventional genetic testing workflows taking weeks. Studies in neonatal intensive care units demonstrate that rapid genome sequencing changes clinical management in 30-40% of cases, sometimes identifying actionable diagnoses that conventional testing misses. As costs continue to fall, universal newborn genome sequencing is being piloted in several countries.

Example 3: Pharmacogenomics

Drug response varies partly due to genetic polymorphisms in drug-metabolising enzymes, transporters, and targets. CYP2C19 poor metabolisers cannot activate clopidogrel (prodrug requiring CYP2C19); prescribing antiplatelet therapy without genotyping risks clinical failure. CYP2D6 ultra-metabolisers rapidly metabolise codeine to toxic morphine levels causing overdose. HLA-B*57:01 carriers develop severe hypersensitivity to abacavir (HIV drug); prospective HLA testing is now mandatory. Pharmacogenomics is entering clinical practice, with preemptive genotyping panels guiding medication selection before adverse events occur.

Example 4: Direct-to-Consumer Genetic Testing

Companies like 23andMe and AncestryDNA offer consumer genomics—ancestry, trait reports, and health risk information from SNP arrays. Millions of consumers have been tested, creating large databases useful for research (GWAS with millions of participants). Concerns include privacy (law enforcement access to genetic databases for forensic matching), unexpected findings (paternity surprises, unknown disease risk), and interpretation accuracy. Polygenic risk score reports for Alzheimer's disease, type 2 diabetes, and coronary artery disease are provided with growing evidence base for their clinical utility.

Example 5: Prenatal Genetic Diagnosis

Cell-free fetal DNA (cffDNA) in maternal plasma enables non-invasive prenatal testing (NIPT) for trisomies 21, 18, 13 and sex chromosomal aneuploidies from 10 weeks gestation with sensitivity/specificity over 99%, largely replacing amniocentesis for chromosomal screening. Whole-genome sequencing of cffDNA detects rare genomic copy number variants and even monogenic disorders. Preimplantation genetic testing of IVF embryos screens for chromosomal abnormalities and monogenic diseases before transfer, enabling selection of unaffected embryos for implantation in families carrying severe genetic disease mutations.

Example 6: Somatic Genomics in Cancer

Cancer genome sequencing reveals somatic mutations driving malignancy. The Cancer Genome Atlas (TCGA) and PCAWG projects catalogued mutations across thousands of cancers, identifying driver genes, mutational signatures (UV-induced C>T in melanoma; APOBEC-related in many cancers), and oncogenic pathways. Liquid biopsy—detecting circulating tumour DNA in blood—enables non-invasive cancer detection, treatment monitoring, and early relapse detection. Tumour mutation burden and microsatellite instability—derived from tumour sequencing—predict response to checkpoint immunotherapy, guiding patient selection.

Example 7: Rare Disease Genomic Diagnosis

Approximately 6000 rare genetic diseases affect 300 million people worldwide; 50% affect children and many are life-threatening. Whole-exome or genome sequencing achieves diagnosis in 25-40% of previously undiagnosed patients with rare disease, ending diagnostic odysseys often lasting years. Matchmaker Exchange connects clinicians worldwide caring for patients with similar rare variants, enabling collaborative diagnosis and gene discovery. Once diagnosed, treatment may be available—enzyme replacement for Gaucher disease, specific small molecules for some CFTR mutations in cystic fibrosis, or gene therapy for a growing list of conditions.

Example 8: Functional Genomics with CRISPR Screens

Genome-wide CRISPR loss-of-function and activation screens systematically perturb every gene and measure effects on phenotypes of interest—cell survival, drug resistance, viral infection, differentiation. In cancer cells, screens identify essential genes (potential drug targets) and genes whose loss confers resistance or vulnerability to specific drugs. Single-cell CRISPR screens (Perturb-seq) simultaneously profile transcriptome and perturbation identity, mapping gene regulatory networks at scale. These systematic approaches provide unbiased genetic functional genomics beyond hypothesis-driven candidate gene studies.

Try it live

Everything above runs in your browser — open Genetics and Genomics: DNA Helix Explorer and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.